Femogesal 0.03 / 0.075 mg 21 tablets

Tradename:

Femogesal

Composition:

Each tablet contains:

Gestodene 75 mcg

Ethinylestradiol 30 mcg

Auxiliary components:

sodium calcium edetate, lactose monohydrate, corn starch, povidone, magnesium stearate.

Shell composition: sucrose, povidone, polyglycol, calcium carbonate, talc, mountain glycolic wax (montanglycolic wax).

Properties:

The combination of gestodene + ethinyl estradiol inhibits the secretion of gonadotropic hormones; inhibits the maturation of follicles; interferes with the ovulation process; reduces the susceptibility of the endometrium to the blastocyst and increases the viscosity of the cervical secretion, making it difficult for sperm to enter the uterine cavity.

In women taking COCs, the cycle becomes more regular, the soreness and intensity of menstrual bleeding decrease, as a result of which one of the risk factors for the development of iron deficiency anemia decreases. Taking COCs with a high content of

ethinyl estradiol (50 mcg) reduces the risk of developing ovarian and endometrial cancer.

There are no data confirming this pharmacological effect for COC preparations with a lower ethinyl estradiol content.

Indications:

Oral contraception.

Method of administration and dosage:

Femozhesal is taken orally 1 tab. / Day at the same time without gaps for 21 days, followed by a 7-day break before taking the next package.

Reception Femogesal begins on the 1st day of menstruation.

When switching from another oral contraceptive

Take 1 tablet 7 days after the end of the previous contraceptive containing 21 tablets. After the end of taking Femozhesal, in the absence of bleeding for 6-7 days, pregnanc must be excluded before starting the next package of the contraceptive.

If one or more tablets are missed:

If the pass in taking the drug is no more than 12 hours, you must urgently take the pill. The next pill should be taken at the scheduled time.

If the gap in taking the drug is more than 12 hours, contraceptive safety cannot be guaranteed. It is urgent to take the missed pill, even if two pills are taken on the same day. Then continue the course as usual, while it is necessary to use additional methods of contraception (condoms, spermicides) until the end of the menstrual cycle and the beginning of the next package.

Contraindications:

-increased sensitivity to drug components;

• thromboembolism of the arteries at present or in history (myocardial infarction, cerebrovascular disorders);
• venous thromboembolism at present or in anamnesis (phlebitis, pulmonary embolism)

• arterial hypertension, coronaropathy, valvulopathy, heart rhythm disturbances due to thrombus formation;

-metabolic disorders: diabetes mellitus with micro- and macroangiopathy, hyperlipidemia (hypertriglyceridemia, hypercholesterolemia);

• malignant tumors of the mammary gland;
• malignant tumors of the uterus;
• pituitary tumors with hyperprolactinemia, galactorrhea;
• bleeding from the genital tract of unclear etiology;

-collagenosis;

-porphyria;

-severe liver disease;

-cholestasis;

obesity (BMI> 30 kg / m2);

-otosclerosis;

• renal dysfunction;

-genital herpes;

-pregnancy;

-period of lactation (breastfeeding);

-smoking;

• fructose intolerance, glucose / galactose malabsorption syndrome, sucrase / isomaltase or lactase deficiency.

Precautions:

Before using Femozhesal, it is necessary to carry out a complete medical examination:

-control of blood pressure, mammary gland cervicovaginal mucus, triglyceride, cholestero , glucose levels.

With caution and special attention, the drug should be prescribed to patients with epilepsy, migraine, bronchial asthma, a history of vascular disorders, varicose veins.

Side effects:

Often:

-decreased libido, depression, neurosis;

-nausea, abdominal pain;

-acne;

-peripheral edema;

• candidiasis vaginitis.

Sometimes:

• migraine, vertigo, visual impairment;
• changes in appetite,

• bloating;

-chloasma, hirsutism, alopecia;

-arterial hypertension;

-hyperlipidemia (hypertriglyceridemia and / or hypercholesterolemia).

Storage method:

At a temperature not higher than 30 degrees.

Packaging:

The cardboard box holds a blister of 21 tablets.